What have we learnt from the last ten years of ART?

被引：0
|
作者：
Venter, W. D. F. [1 ,2 ]
机构：
[1] Univ Witwatersrand, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa
[2] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Johannesburg, South Africa
来源：
SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE | 2014年 / 15卷 / 01期
关键词：
D O I：
10.7196/SAJHIVMED.1029
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：39 / 40
页数：2
相关论文
共 50 条
  • [31] What have we learnt from Covid?
    Salter, Mark Steven
    BJPSYCH BULLETIN, 2021, 45 (02): : 122 - 123
  • [32] Coronavirus disease 2019 and cardiovascular disease: what we have learnt during the last 2 years
    Bonfioli, Giovanni
    Tomasoni, Daniela
    Metra, Marco
    Adamo, Marianna
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2022, 23 (11) : 710 - 714
  • [33] What Have We Learnt From Chernobyl? What Have We Still To Learn?
    Thomas, G. A.
    Tronko, M. D.
    Tsyb, A. F.
    Tuttle, R. M.
    CLINICAL ONCOLOGY, 2011, 23 (04) : 229 - 233
  • [34] 5 Years of antimicrobial monitoring - What have we learnt?
    Moffett, A.
    CATTLE PRACTICE, 2018, 26 : 140 - 140
  • [35] Candesartan in the treatment of hypertension: what have we learnt in the last decade?
    Barrios, Vivencio
    Escobar, Carlos
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (06) : 957 - 968
  • [36] 10 Years of belimumab experience: What have we learnt?
    Levy, Roger A.
    Gonzalez-Rivera, Tania
    Khamashta, Munther
    Fox, Norma Lynn
    Jones-Leone, Angela
    Rubin, Bernie
    Burriss, Susan W.
    Gairy, Kerry
    van Maurik, Andre
    Roth, David A.
    LUPUS, 2021, 30 (11) : 1705 - 1721
  • [37] 10 Years of Reminding Technologies: What Have We Learnt?
    Nugent, Chris
    SMART HOMES AND HEALTH TELEMATICS, 2015, 8456 : XV - XVI
  • [38] Thirty Years of Monitoring in England - What Have We Learnt?
    Williams, Jim
    CONSERVATION AND MANAGEMENT OF ARCHAEOLOGICAL SITES, 2012, 14 (01) : 442 - 457
  • [39] 20 years of rituximab treatment: what have we learnt?
    Renner, Christoph
    FUTURE ONCOLOGY, 2019, 15 (36) : 4119 - 4122
  • [40] 13 years of trabectedin, 5 years of Yondelis®: what have we learnt?
    Le Cesne, Axel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (06) : 11 - 19
12345